Ann: OrthoATI Rotator Cuff Study Success With Cross-Over Patients, page-37

I, like you, am frustrated with progress. But i, like most here ,am baffled at the sp especially given recent deals and cash in bank. We are in a better position than half the companies on the asx. Fda, tga approved, massive upside with the products we have.

But here's the thing, if the sp was $3-4 which is where it should be, we'd all be commending management.

Once the dollars start rolling in there will be a scramble for people to get their hands on occ shares. Hang in just a few more years, you deserve the reward for patience as much as any on here.